Alterations in coagulation and fibrinolysis during sepsis

Shock

Volumn 5, Issue 3, 1996, Pages 223-228

  Kidokoro, Akio ^a   Iba, Toshiaki ^a,b   Fukunaga, Masaki ^a   Yagi, Yoshihiro ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; ANTIPLASMIN; ANTITHROMBIN III; ANTITHROMBIN III PROTEASE COMPLEX; ANTITHROMBIN III-PROTEASE COMPLEX; PEPTIDE HYDROLASE; PLASMIN; PLASMIN PLASMIN INHIBITOR COMPLEX; PLASMIN-PLASMIN INHIBITOR COMPLEX; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD; BLOOD CLOTTING DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HUMAN; MALE; METABOLISM; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY; PHYSIOLOGY; SEPSIS; SYNDROME; VASCULAR ENDOTHELIUM;

ADULT; AGED; ANTIFIBRINOLYTIC AGENTS; ANTIPLASMIN; ANTITHROMBIN III; BLOOD COAGULATION DISORDERS; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PEPTIDE HYDROLASES; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SEPSIS; SYNDROME; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0030100155     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199603000-00010     Document Type: Article

References (30)

1. Creasey AA, Stevens P, Kenney J, Allison AC, Warren K, Catlett R, Hinshaw L, Taylor FB Jr: Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coli. Circ Shock 33:84-91, 1991.
2. Levi M, ten Cate H, van der Poll, van Deventer SJH: Pathogenesis of disseminated intravascular coagulation in sepsis. J Am Med Assoc 270: 975-979, 1993.
3. Waage A, Halstensen A, Espevik T: Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1:355-357, 1987.
4. Busund R, Lindsetmo RO, Rasmussen LT, Rokke O, Rekvig OP, Revhaug A: Tumor necrosis factor and interleukin 1 appearance in experimental Gram-negative septic shock. Arch Surg 126:591-597, 1991.
5. van Devender SJH, Buller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A: Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 76:2520-2526, 1990.
6. ten Cate H, Brandjes DPM, Wolters HJ, van Deventer SJH: Disseminated intravascular coagulation: Pathophysiology, diagnosis, and treatment. New Horizons 2:312-323, 1993.
7. Maruyama I: Thrombomodulin: An endothelial anticoagulant-its structure, function and expression. Jpn Circ J 56:187-191, 1992.
8. Takahashi H, Ito S, Hanano M, Wada K, Niwano H, Seki Y, Shibata A: Circulating thrombomodulin as a novel endothelial cell marker: Comparison of its behavior with von Willebrand factor and tissue-type plasminogen activator. Am J Hematol 41:32-39, 1992.
9. Members of the American college of chest physicians/society of critical care medicine consensus conference committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapeutics in sepsis. Crit Care Med 20:864-874, 1992.
10. Kodama N, Maegawa T, Takada M, Tanaka H, Gonmori H: Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIG patients collected by the Research Committee on DIC in Japan. Biol Haemotol 49:265-275, 1987.
11. Hayashi T, Suzuki K: Monoclonal antibodies for human thrombomodulin which recognize binding sites for thrombin and protein C. J Biochem 108:874-878, 1990.
12. Kodama S, Uchijima E, Nagai M, Mikawatani K, Hayashi T, Suzuki K: One-step sandwich enzyme immunoassay for soluble human thrombomodulin using monoclonal antibodies. Clin Chem Acta 192:191-200, 1990.
13. Gutierrez G: Cellular energy metabolism during hypoxia. Crit Care Med 19:619-626, 1991.
14. Regoeczi E, Brain MC: Organ distribution of fibrin in disseminated intravascular coagulation. Br J Haematol 17:73-79, 1969.
15. Muller-Berghaus G: Pathophysiologic and biochemical events in disseminated intravascular coagulation: Dysregulation of procoagulant and anti-coagulant pathways. Semin Thromb Hemost 15:58-87, 1989.
16. Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU: Endotoxin enhances tissue factor and supresses thrombomodulin expression on human vascular endothelium in vitro. J Clin Invest 79:124-130, 1987.
17. Conway EM, Bach R, Rosenberg RD, Konigsberg WH: Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells. Thromb Res 53:231-241, 1989.
18. Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MA: Recombinant tumor necrosis factor produces pro-coagulant activity in cultured human vascular endothelium. Proc Natl Acad Sci USA 83: 4533-4537, 1986.
19. Conkling PR, Greenberg CS, Weinberg JB: Tumor necrosis factor induces tissue factor-like activity in human Jeukemia cell line U937 and peripheral blood monocytes. Blood 72:128-133, 1988.
20. Levi M, ten Cate H, Bauer KA, Buller HR, ten Cate JW, Rosenberg RD: Dose-dependent endotoxin induced cytokine release and coagulation activation in chimpanzees. Thromb Haemost 65:793, 1991.
21. Wada H, Minamikawa K, Wakita Y, et al: Hemostatic study before onset of disseminated intravascular coagulation. Am J Hematol 43:190-194, 1993.
22. Voss R, Matthias FR, Borkowski G, Reitz: Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit. Br J Haematol 75:99-102, 1990.
23. Suffredini AF, Harpel PC, Parillo JE: Promotion and subsequent inhibition of plasminogen activator after administration of intravenous endotoxin to normal subjects. N Engl J Med 320:1165-1172, 1989.
24. van der Poll T, Levi M, Buller HR, et al: Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med 174:729-732, 1991.
25. Lorente JA, Garcia FLJ, Landin L, de Pabro R, Torrado C, Renes E, Garcia AA: Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest 103:1536-1542, 1993.
26. Hesselvik JF, Blomback M, Brodin B, Maller R: Coagulation, fibrinolysis, and kallikrein systems in sepsis: Relation to outcome. Crit Care Med 17:724-733, 1989.
27. Pralong G, Calandra T, Glauser MP, et al: Plasminogen activator inhibitor 1: A new prognostic marker in septic shock. Thromb Haemost 61:459-462, 1989.
28. Iba T, Fukunaga T, Fukunaga M, Kidokoro A, Yagi Y: Changes in plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in sepsis with organ failure. Jpn J Assoc Acute Med 5:365-372, 1994.
29. Ishii H, Majerus PW: Thrombomodulin is present in human plasma and urine. J Clin Invest 76:2178-2181, 1985.
30. Wada H, Ohiwa M, Kaneko T, et al: Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation. Am J Hematol 39:20-24, 1992.